Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development

Dana C. Dolinoy1,2,3, Dale Huang4,5, Randy L. Jirtle4,2,3
1*Department of Radiation Oncology and University Program in Genetics and Genomics, Duke University, Durham, NC 27710, USA.
2Integrated Toxicology and Environmental Health Program, Duke University, Durham, NC 27708
3University Program in Genetics and Genomics, Duke University, Durham, NC 27710; and
4Department of Radiation Oncology; and
5Duke University

Tóm tắt

The hypothesis of fetal origins of adult disease posits that early developmental exposures involve epigenetic modifications, such as DNA methylation, that influence adult disease susceptibility. In utero or neonatal exposure to bisphenol A (BPA), a high-production-volume chemical used in the manufacture of polycarbonate plastic, is associated with higher body weight, increased breast and prostate cancer, and altered reproductive function. This study shows that maternal exposure to this endocrine-active compound shifted the coat color distribution of viable yellow agouti ( A vy ) mouse offspring toward yellow by decreasing CpG (cytosine-guanine dinucleotide) methylation in an intracisternal A particle retrotransposon upstream of the Agouti gene. CpG methylation also was decreased at another metastable locus, the CDK5 activator-binding protein ( Cabp IAP ). DNA methylation at the A vy locus was similar in tissues from the three germ layers, providing evidence that epigenetic patterning during early stem cell development is sensitive to BPA exposure. Moreover, maternal dietary supplementation, with either methyl donors like folic acid or the phytoestrogen genistein, negated the DNA hypomethylating effect of BPA. Thus, we present compelling evidence that early developmental exposure to BPA can change offspring phenotype by stably altering the epigenome, an effect that can be counteracted by maternal dietary supplements.

Từ khóa


Tài liệu tham khảo

10.1038/nature02725

10.1152/physrev.00053.2003

10.1038/nrg2045

10.1210/en.2005-1122

10.1289/ehp.8700

10.1128/MCB.23.15.5293-5300.2003

10.1096/fasebj.12.11.949

10.1038/ng0994-59

10.1016/S0168-9525(02)02709-9

10.1038/15490

10.1093/jn/127.9.1902S

10.1289/ehp.7534

10.1016/j.mce.2006.04.033

10.1289/ehp.00108931

10.1093/nar/29.13.e65

10.1037/0022-3514.51.6.1173

10.1093/nar/gkh914

10.1093/jn/132.8.2393S

10.1093/genetics/88.3.529

10.1093/oxfordjournals.jhered.a110206

10.1016/S0278-6915(03)00031-0

10.1021/tx025548t

10.1002/mc.10147

S Li, K Washburn, R Moore, T Uno, C Teng, R Newbold, J McLachlan, M Negishi Cancer Res 57, 4356–4359 (1997).

10.1158/0008-5472.CAN-06-0516

10.1093/jn/132.8.2419S

10.1158/1078-0432.CCR-05-0406

10.1093/jn/137.1.223S

10.1002/path.1024

10.1038/nrc1279

10.1016/j.reprotox.2006.10.001

10.1016/j.reprotox.2006.12.010

10.1093/jn/132.3.552S

10.1289/ehp.95103s7103

10.1210/en.2003-0076

10.1016/S0021-9258(18)45614-1

10.1080/01635589309514265

10.1080/02652038509373531

10.1196/annals.1365.033

10.1210/en.2005-1164

10.1126/science.1108190

10.1073/pnas.0607090103

10.1289/ehp.7713

10.1080/10807030490513883

10.1093/hmg/ddi484